With the open letter published in *EJNMMI Radiopharmacy and Chemistry* by an international working group of experts, the EJNMMI journal family endorses the application of the guidelines in contributions to the journals.

Attached to the letter by the working group is a three-page summary highlighting the most relevant issues used in the notation of radiopharmaceuticals and related terms.

The full paper with all recommendations is published in "Consensus nomenclature rules for radiopharmaceutical chemistry**---**setting the record straight, Coenen, H.H., Gee A.D. et al., *Nuclear Medicine and Biology*, **v**olume 55, v**--**xi (2017) (10.1016/j.nucmedbio.2017.09.004)".

All Editors-in-Chiefs of the EJNMMI journals strongly recommend all manuscripts meet these guidelines upon submission. In addition, all reviewers will be asked to be aware of the guidelines and wherever possible to check if the guidelines are followed.
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